Explore the full record of transactions filed by 杨莉, Director. Officer active across 1 companies, notably 派林生物. In total, 46 filings have been published. The latest transaction was filed on 25 April 2025 — Purchase. Regulator: AMF. The full history is openly available.
Declarations 46 total
80,000 shares
SSE:173000009835496400 · 27 Nov 2025
30,000 shares
SSE:173000009827576740 · 24 Nov 2025
30,000 shares
SSE:173000009783837660 · 17 Nov 2025
Executives ● Sale福 福鞍股份 11 SSE 8,000 shares
SSE:173000009783837730 · 17 Nov 2025
10,000 shares
SSE:173000009775577400 · 13 Nov 2025
69,900 shares
SSE:173000009738442370 · 11 Nov 2025
20,000 shares
SSE:173000009726371520 · 10 Nov 2025
Executives ● Sale福 福鞍股份 11 SSE 20,000 shares
SSE:173000009717809440 · 6 Nov 2025
Executives ● Sale福 福鞍股份 11 SSE 10,000 shares
SSE:173000009717809470 · 6 Nov 2025
6,000 shares
SSE:173000009717809800 · 6 Nov 2025
50,000 shares
SSE:173000009712471970 · 5 Nov 2025
Executives ● Purchase派 派林生物 18 SZSE €19,584 7,500 shares
SZSE:173000008868500580 · 25 Apr 2025
Ideal exit: 20 Jan 2026 (T+270) Executives ● Purchase派 派林生物 22 SZSE €13,056 5,000 shares
SZSE:173000008868500400 · 25 Apr 2025
Ideal exit: 20 Jan 2026 (T+270) Executives ● Purchase派 派林生物 7 SZSE €542 200 shares
SZSE:173000008717793300 · 24 Feb 2025
Ideal exit: 21 Nov 2025 (T+270) Executives ● Purchase派 派林生物 7 SZSE €5,572 2,000 shares
SZSE:173000008552387420 · 13 Feb 2025
Ideal exit: 10 Nov 2025 (T+270) Executives ● Purchase派 派林生物 18 SZSE €4,321 1,500 shares
SZSE:173000008451201340 · 14 Jan 2025
Ideal exit: 11 Oct 2025 (T+270) Executives ● Purchase派 派林生物 18 SZSE €2,185 800 shares
SZSE:173000008409120800 · 7 Jan 2025
Ideal exit: 4 Oct 2025 (T+270) Executives ● Purchase派 派林生物 11 SZSE €27,529 10,000 shares
SZSE:173000008405393340 · 6 Jan 2025
Ideal exit: 3 Oct 2025 (T+270) Executives ● Purchase派 派林生物 7 SZSE €5,506 2,000 shares
SZSE:173000008405393300 · 6 Jan 2025
Ideal exit: 3 Oct 2025 (T+270) Executives ● Purchase派 派林生物 11 SZSE €14,076 5,000 shares
SZSE:173000008396452540 · 2 Jan 2025
Ideal exit: 29 Sept 2025 (T+270) Executives ● Purchase派 派林生物 18 SZSE €5,631 2,000 shares
SZSE:173000008396452580 · 2 Jan 2025
Ideal exit: 29 Sept 2025 (T+270) Executives ● Purchase尤 尤夫股份 11 SZSE 5,700 shares
SZSE:173000008264542800 · 14 Nov 2024
Ideal exit: 11 Aug 2025 (T+270) Executives ● Purchase尤 尤夫股份 7 SZSE 4,000 shares
SZSE:173000008138114020 · 30 Sept 2024
Ideal exit: 27 Jun 2025 (T+270) Executives ● Purchase尤 尤夫股份 7 SZSE 8,000 shares
SZSE:173000007882566600 · 25 Jul 2024
Ideal exit: 21 Apr 2025 (T+270) Executives ● Sale派 派林生物 7 SZSE 3,500,000 shares
SZSE:173000006682573300 · 26 Jun 2023
25 of 46 declarations
Load more (21 remaining) About 杨莉 Yang Li is a Director at Pailin Biotechnology, where she participates in corporate governance and strategic decision-making. Her experience in the biotechnology sector allows her to make significant contributions to the company.